{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T21:40:56Z","timestamp":1783028456870,"version":"3.54.6"},"reference-count":13,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,1,29]],"date-time":"2024-01-29T00:00:00Z","timestamp":1706486400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"DOI":"10.3389\/fendo.2024.1351350","type":"journal-article","created":{"date-parts":[[2024,1,29]],"date-time":"2024-01-29T04:40:58Z","timestamp":1706503258000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Editorial: Treatment outcomes, comorbidities and impact of discordant biochemical values in acromegaly"],"prefix":"10.3389","volume":"15","author":[{"given":"Claudia","family":"Campana","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva Christine","family":"Coopmans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabrina","family":"Chiloiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,1,29]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eprac.2021.12.017","article-title":"Personalized medical treatment of patients with acromegaly: A review","volume":"28","author":"Lim","year":"2022","journal-title":"Endocrine practice: Off J Am Coll Endocrinol Am Assoc Clin Endocrinologists"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgz096","article-title":"A consensus on the diagnosis and treatment of acromegaly comorbidities: an update","volume":"105","author":"Giustina","year":"2020","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1007\/s11154-020-09588-z","article-title":"Multidisciplinary management of acromegaly: A consensus","volume":"21","author":"Giustina","year":"2020","journal-title":"Rev Endocrine Metab Disord"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/j.wneu.2017.01.110","article-title":"Endoscopic endonasal versus microscopic transsphenoidal surgery for recurrent and\/or residual pituitary adenomas","volume":"101","author":"Esquenazi","year":"2017","journal-title":"World Neurosurg"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.2147\/TCRM.S183360","article-title":"Octreotide-resistant acromegaly: challenges and solutions","volume":"16","author":"Corica","year":"2020","journal-title":"Ther Clin Risk Manage"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1530\/ERC-12-0020","article-title":"AIP expression in sporadic somatotropinomas is a predictor of the response to octreotide LAR therapy independent of SSTR2 expression","volume":"19","author":"Kasuki","year":"2012","journal-title":"Endocrine-Related Cancer"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1111\/cen.14706","article-title":"Molecular genetic testing in the management of pituitary disease","volume":"97","author":"Coopmans","year":"2022","journal-title":"Clin Endocrinol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1007\/s11102-023-01360-1","article-title":"Consensus on criteria for acromegaly diagnosis and remission","author":"Giustina","year":"2023","journal-title":"Pituitary"},{"key":"B9","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1210\/clinem\/dgaa859","article-title":"Discordant GH and IGF-1 results in treated acromegaly: impact of GH cutoffs and mean values assessment","volume":"106","author":"Campana","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2008-1371","article-title":"The utility of oral glucose tolerance testing for diagnosis and assessment of treatment outcomes in 166 patients with acromegaly","volume":"94","author":"Carmichael","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2007-2104","article-title":"Divergence between growth hormone and insulin-like growth factor-i concentrations in the follow-up of acromegaly","volume":"93","author":"Alexopoulou","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1007\/s12020-020-02387-1","article-title":"Discordant biological parameters of remission in acromegaly do not increase the risk of hypertension or diabetes: a study with the Liege Acromegaly Survey database","volume":"70","author":"Amodru","year":"2020","journal-title":"Endocrine"},{"key":"B13","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1093\/ejendo\/lvad105","article-title":"Increase in intracellular and extracellular myocardial mass in patients with acromegaly: a cardiac magnetic resonance imaging study","volume":"189","author":"Wolf","year":"2023","journal-title":"Eur J Endocrinol"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2024.1351350\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,29]],"date-time":"2024-01-29T04:41:00Z","timestamp":1706503260000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2024.1351350\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,29]]},"references-count":13,"alternative-id":["10.3389\/fendo.2024.1351350"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2024.1351350","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,29]]},"article-number":"1351350"}}